CXCR5 was expressed in B cells, TFH, and CD8 TRM, while its ligand, CXCL13, was expressed in TFH and CD8 TRM, suggesting that the putative role of CXCR5-CXCL13 for T-B interaction in thymoma. This evidence concerns the gene CD8A and thymoma.